Clinical Trials Logo

Clinical Trial Summary

To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.


Clinical Trial Description

The present study comparing the safety and efficacy of 1.25mg/0.05mL Bevacizumab injection via the intracameral route versus the intravitreal route in treating the neovascular glaucoma ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03648814
Study type Interventional
Source Prince of Songkla University
Contact Assoc.Prof.Weerawat Kiddee, MD
Phone +66874954626
Email kweerawat@hotmail.com
Status Recruiting
Phase N/A
Start date August 1, 2018
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT01908816 - An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. Phase 3
Completed NCT03639675 - Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied Phase 3
Not yet recruiting NCT02914626 - Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study Phase 3
Not yet recruiting NCT05593354 - MicroPulse TLT - UK Study
Completed NCT03187418 - Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma N/A
Completed NCT02647515 - Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma Phase 4
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Completed NCT04215575 - Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases N/A
Completed NCT01922154 - Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma Phase 4
Completed NCT04214847 - The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases N/A
Completed NCT02396316 - Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients Phase 3